Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112409404B details a continuous method for high-purity BDP. Achieve >97% yield and <50ppm impurities. Ideal for reliable flame retardant supplier partnerships.
Novel synthesis route for fluopicolide intermediate avoids cyanide. Offers cost reduction and supply reliability for agrochemical manufacturing partners globally.
Patent CN113603655B details a mild DABCO-catalyzed route for thiazolidine derivatives, offering significant cost reduction and scalable manufacturing for fine chemical intermediates.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Novel solid-acid catalyzed route for high-purity crosslinkers. Reduces equipment corrosion and simplifies purification for reliable supply chain partners.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Patent CN116640737A reveals novel BsER mutants for asymmetric reduction. Enables cost reduction in API manufacturing with high stereoselectivity and supply reliability.
Patent CN116640737A reveals novel BsER mutants for chiral ketone reduction. Enables high-purity pharmaceutical intermediates with reduced manufacturing costs and enhanced supply reliability.
Novel gold-catalyzed route ensures safe scalable production of high-purity nucleoside analogs with significant cost and supply chain advantages for pharmaceutical partners.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN116589417B reveals ionic liquid catalysis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable green chemistry.
Novel ADH mutant enables high-purity Brivaracetam intermediate production with superior stereoselectivity and cost-effective supply chain solutions.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for synthesizing paclitaxel and docetaxel side chains, offering significant cost reduction and supply chain stability.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for paclitaxel synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1276905C reveals a water-based synthesis for dichloroaryl ethers using KI/PTC catalysis. Achieve high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1276905C reveals a water-based method for synthesizing dichloroaryl ethers using cheap chloroalkanes, offering significant cost reduction and high purity for pharmaceutical intermediates.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Patent CN101270091A details a clean hydrazine reduction and zinc chloride separation method for high-purity albendazole intermediates.